Ventralex (hernia mesh)

2022: Becton Dickinson to pay $4.8 million to patient who installed defective mesh to treat hernia

At the end of August 2022, it became known that the C.R. Bard division of Becton Dickinson agreed to pay $4.8 million in a lawsuit related to its hernia nets. The complaint was filed in court by the American, who said he had serious complications after implanting a hernial mesh.

Paul Trevino and his wife, Ranenn, argued in a 2018 lawsuit that Ventralex hernia repair mesh from C.R. Bard, owned by Becton Dickinson, gnawed into his tissue, causing pain and inflammation, ultimately leading to the need for corrective surgery, the report said.

Ventralex (hernia mesh)

Ventralex implant is designed specifically for hernioplasty of umbilical, small ventral hernias and closure of postoperative defects. Thanks to the macroporous weaving of a mesh of uncoated polypropylene monofilament, the bulk of tissue germination occurs within a short time. The visceral side is made of submicron ePTFE and acts as a permanent anti-surge barrier, providing protection throughout the healing period. The mesh is equipped with pockets and tapes of positioning and fixation, a ring of shape memory for accurate and fast installation of the implant.

A Rhode Island jury reached a verdict after a month-long trial. A total of more than 30,000 similar claims related to herniated mesh devices have been sent to Becton Dickinson. Mesh devices have been the subject of litigation over the years, proving to be potentially one of the greatest modern failures in medical technology. Pelvic mesh products especially caused a lot of trouble. In 2020, Becton Dickinson agreed to pay $60 million to 48 US states to settle allegations that its C.R. Bard unit fraudulently advertised transvaginal surgical mesh devices.^[1]

Notes